company background image
BIOS logo

BioPlus Acquisition NasdaqGM:BIOS Stock Report

Last Price

US$10.80

Market Cap

US$209.1m

7D

-0.2%

1Y

7.3%

Updated

10 Oct, 2023

Data

Company Financials

BioPlus Acquisition Corp.

NasdaqGM:BIOS Stock Report

Market Cap: US$209.1m

BioPlus Acquisition Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioPlus Acquisition
Historical stock prices
Current Share PriceUS$10.80
52 Week HighUS$11.68
52 Week LowUS$10.05
Beta0
1 Month Change-0.046%
3 Month Change1.46%
1 Year Change7.31%
3 Year Changen/a
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Recent updates

Shareholder Returns

BIOSUS Capital MarketsUS Market
7D-0.2%1.7%0.4%
1Y7.3%32.8%28.8%

Return vs Industry: BIOS matched the US Capital Markets industry which returned 8% over the past year.

Return vs Market: BIOS underperformed the US Market which returned 14.1% over the past year.

Price Volatility

Is BIOS's price volatile compared to industry and market?
BIOS volatility
BIOS Average Weekly Movement0.5%
Capital Markets Industry Average Movement3.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: BIOS has not had significant price volatility in the past 3 months.

Volatility Over Time: BIOS's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021n/aR. Ross Haghighathttps://bioplusspac.com

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

BioPlus Acquisition Corp. Fundamentals Summary

How do BioPlus Acquisition's earnings and revenue compare to its market cap?
BIOS fundamental statistics
Market capUS$209.07m
Earnings (TTM)US$5.79m
Revenue (TTM)n/a

36.1x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOS income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other Expenses-US$5.79m
EarningsUS$5.79m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-39.6%

How did BIOS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.